Company Profile
Ventana Medical Systems, Inc.
Company Overview
Ventana Medical Systems, Inc., a member of the Roche Group, is a world leading cancer diagnostic company. An innovator of tissue-based tests that enable personalized healthcare, Ventana develops and manufactures medical diagnostic instruments and reagent systems that provide leading-edge automation technology for the slide-based diagnosis of cancer and infectious disease. In addition, the company offers premier workflow solutions designed to improve laboratory workflow efficiency, providing automated safeguards to enhance the quality of patient healthcare worldwide. Ventana’s pioneering products and solutions are used globally in the world’s most advanced hospital-based histology laboratories, independent reference laboratories, medical research centers, and pharmaceutical companies. To learn more about Ventana please visit www.ventanamed.com.
Company History
Dr. Thomas Grogan was a practicing pathologist at the University of Arizona when he founded Ventana more than 20 years ago on the strength of his vision for automating the manual IHC staining process. In 1991, Ventana launched its first ground-breaking instrument and reagent system and went public in 1996 to raise capital to fund further research. Today, we’re a global organization providing healthcare professionals with superior automated instrument and reagent systems that standardize and speed slide staining in support of identifying treatment solutions that help people live better and longer lives.
Notable Products / Brands
DISCOVERY® XT system, NexES® Special Stainer, BenchMark® XT system, VIAS™ (Ventana Image Analysis System), and the SYMPHONY® system
Notable Accomplishments / Recognition
Ventana’s first product was an instrument-reagent system designed to automate IHC staining. At the time, all IHC staining was performed manually, or via rudimentary automation. The Ventana system revolutionized the category and the Company has gone on to refine its systems culminating in the development of the “baking through staining” technology available on the BenchMark® platform which won the Medical Design Excellence Gold Medal award in the In vitro Diagnostics category in 2001.
In 2006 Ventana launched the SYMPHONY® system, its first, fully automated, one-touch H&E (Hematoxylin & Eosin) staining platform propelling the Company into the primary staining market and revolutionizing H&E slide preparation. In 2007 the SYMPHONY® system won the Medical Design Excellence Gold Medal award in the in vitro Diagnostics category.
Benefits
At Ventana, benefits are an important part of each employees total compensation package. Accordingly, we offer a menu of competitive benefit options and allow employees choices in designing a program that best suits their individual and family needs.